Not Yet Recruiting NA INTERVENTIONAL 3-arm
NCT07397845
Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial (SPARX RCT)
Sponsor: Translumina GmbH
Interventions
Agent Drug Eluting Stent Protégé and Protégé NC
Updated 1 time since 2026 Last updated: Feb 2, 2026 Started: Mar 31, 2026 Primary completion: Apr 30, 2028 Completion: Apr 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Coronary Artery Disease and Drug Eluting Balloon, this trial is actively recruiting participants. The trial is conducted by Translumina GmbH and has accumulated 1 data snapshot since 2026. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Translumina GmbH
Data source: Translumina GmbH
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.